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Formin-dependent TGF-β signaling for epithelial 
to mesenchymal transition
ABSTRACT The role of distinct actin filament architectures in epithelial plasticity remains 
incompletely understood. We therefore determined roles for formins and the Arp2/3 com-
plex, which are actin nucleators generating unbranched and branched actin filaments, respec-
tively, in the process of epithelial to mesenchymal transition (EMT). In clonal lung, mammary, 
and renal epithelial cells, the formin activity inhibitor SMIFH2 but not the Arp2/3 complex 
activity inhibitor CK666 blocked EMT induced by TGF-β. SMIFH2 prevented the proximal 
signal of increased Smad2 phosphorylation and hence also blocked downstream EMT mark-
ers, including actin filament remodeling, decreased expression of the adherens junction 
protein E-cadherin, and increased expression of the matrix protein fibronectin and the tran-
scription factor Snail. The short hairpin RNA silencing of formins DIAPH1 and DIAPH3 but not 
other formins phenocopied SMIFH2 effects and inhibited Smad2 phosphorylation and chang-
es in Snail and cadherin expression. Formin activity was not necessary for the cell surface 
expression or dimerization of TGF-β receptors, or for nuclear translocation of TAZ, a tran-
scription cofactor in Hippo signaling also regulated by TGF-β. Our findings reveal a previ-
ously unrecognized role for formin-dependent actin architectures in proximal TGF-β signaling 
that is necessary for Smad2 phosphorylation but not for cross-talk to TAZ.
INTRODUCTION
The process of epithelial to mesenchymal transition (EMT) is criti-
cal for normal development and tissue remodeling and contrib-
utes to the progression of diseases such as fibrosis and cancer 
metastasis (Kalluri and Neilson, 2003; Kalluri and Weinberg, 2009; 
Borok et al., 2011). EMT is often considered as two complemen-
tary programs, one morphological and another transcriptional. 
The morphological program includes acquiring a mesenchymal 
cell shape and remodeling of actin filaments from a cortical ring in 
epithelial cells to abundant ventral stress fibers. The transcrip-
tional program includes decreased expression of the adherens 
junction protein E-cadherin, which disrupts cell–cell contacts and 
enables a mesenchymal morphology, and increased production of 
the extracellular matrix proteins fibronectin and collagen, which 
when dysregulated contributes to fibrosis (Xu et al., 2009). 
Although the transcriptional program for EMT is well character-
ized and known to be coordinated primarily through activation of 
transcription factors in the Snail, ZEB, and Twist families that re-
press expression of epithelial genes and activate expression of 
mesenchymal genes (Xu et al., 2009), we know less about how the 
morphological program of EMT is controlled and whether it also 
regulates transcriptional events.
In most EMT models, the morphological program requires activ-
ity of the low-molecular-weight GTPase RhoA and RhoA-kinase 
(ROCK) (Bhowmick et al., 2001; Tavares et al., 2006; Cho and Yoo, 
2007). In selective cell models, cytoskeleton remodeling during 
EMT also depends on changes in the expression of actin regulatory 
proteins, such as moesin (Haynes et al., 2011), zyxin (Mori et al., 
2009), and the formins FHOD1 (Jurmeister et al., 2012) and FMNL2 
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(Li et al., 2010). However, these regulators of the EMT morphologi-
cal program are generally not necessary for transcriptional events 
with EMT.
In the current study we investigated roles for two distinct actin 
nucleators in EMT, in part to resolve how distinct actin architectures 
regulate epithelial plasticity and in part to test whether actin regula-
tors contribute to the transcriptional program of EMT.
We found that activity of formins, which nucleates the assembly of 
unbranched actin filaments (Goode and Eck, 2007; Schonichen and 
Geyer, 2010) but not activity of the Arp2/3 complex, which nucleates 
FIGURE 1: The formin inhibitor SMIFH2 but not the Arp2/3 complex inhibitor CK666 blocks 
EMT of A549 cells with TGF-β. (A) Images of A549 cells maintained in the absence (−) or 
presence (+) of TGF-β for 48 h without (DMSO control) or with SMIFH2 or CK666 
immunolabeled for E-cadherin and stained for F-actin with rhodamine–phalloidin. Representative 
confocal images show mononchromatic LUT of maximum-intensity projections of multiple 
Z-sections. Bar, 20 μm. (B) Quantification of rhodamine–phalloidin intensity for the indicated 
conditions in the absence (−) or presence (+) of TGF-β for 48 h. Data were obtained from 30–35 
cells per condition from three independent cell preparations. (C) Immunoblots of lysates from 
A549 cells maintained in the absence (−) or presence (+) of TGF-β for 48 h without (DMSO 
control) or with SMIFH2 or CK666 probed with antibodies to fibronectin (FN), E-cadherin, Snail, 
phosphorylated MLC (pMLC), and α-tubulin (loading control). (D–F) Semiquantitative 
densitometry of immunoblots described in C probed for E-cadherin (D), fibronectin (E), and Snail 
(F). Boxes show the median ± 95% confidence intervals with whiskers indicating smallest and 
largest values. Statistical analysis by two-tailed t test of six cell preparations for E-caherin, five 
for fibroectin, and four for Snail.
the assembly of branched actin filaments 
(Goley and Welch, 2006), is necessary for 
EMT of clonal lung, mammary, and renal epi-
thelial cells induced by the cytokine trans-
forming growth factor-beta (TGF-β). Inhibit-
ing formins completely blocked both 
transcription and morphological effects, in-
cluding suppressing expression of the tran-
scription factor Snail and blocking decreased 
expression of E-cadherin as well as prevent-
ing actin filament remodeling to contractile 
stress fibers and a mesenchymal cell mor-
phology. A role for formin activity in morpho-
logical and transcriptional events suggested 
it might be necessary for proximal TGF-β sig-
naling, which we confirmed by showing that 
formin but not Arp2/3 complex activity is 
necessary for the initial TGF-β signaling 
event of increased phosphorylation of 
Smad2 (pSmad2 S465/467) and the subse-
quent nuclear translocation of Smad2. Using 
short hairpin RNA (shRNA) for selective for-
min family members, we found that DIAPH1 
and 3 are necessary for increased pSmad2 
and Snail as well as actin filament remodel-
ing, indicating a role in both transcriptional 
and morphological programs. These find-
ings have broad significance for a mechanis-
tic understanding of the many cell behaviors 
regulated by TGF-β and requiring EMT.
RESULTS
Formin but not Arp2/3 complex 
activity is necessary for EMT
We first tested the importance of actin nu-
cleators for EMT of human lung alveolar 
A549 cells by using well-characterized and 
selective pharmacological inhibitors of for-
min and Arp2/3 complex activity. We 
treated cells with TGF-β for 48 h, which in-
duces EMT in diverse epithelial cell types 
(Heldin and Moustakas, 2012), in the ab-
sence and presence of the broad-spectrum 
formin inhibitor SMIFH2 that targets the 
conserved FH2 domain in all 15 mamma-
lian formins (Rizvi et al., 2009; Ganguly 
et al., 2015) and the Arp2/3 complex inhibi-
tor CK666 that stabilizes the inactive con-
formation of the complex by allosterically 
blocking conformational changes in sub-
units (Nolen et al., 2009; Yang et al., 2012). 
Consistent with previous reports on EMT of 
A549 cells with TGF-β (Xi et al., 2014; Rana et al., 2015), control 
cells in the absence of inhibitors had decreased expression of E-
cadherin (Figure 1, A, C, and D), remodeling of actin filaments from 
a cortical ring in epithelial cells to abundant parallel ventral stress 
fibers traversing the mesenchymal cell body (Figure 1, A and B), 
and increased expression of the extracellular matrix protein fibro-
nectin (Figure 1, C and E) and the transcription factor Snail (Figure 
1, D and F). Control cells also had an increase in phosphorylated 
myosin light chain (pMLC; pT18/pS19) (Figure 1C), consistent with 
transition to a mesenchymal contractile phenotype.
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All of these changes with EMT of A549 cells were suppressed by 
the formin inhibitor SMIFH2 but not by the Arp2/3 complex inhibitor 
CK666 (Figure 1, A–F). To confirm the efficacy of CK666 and speci-
ficity of SMFH2, we tested their effects on the velocity of Listeria 
monocytogenes in mammalian host cells. Listeria motility is depen-
dent on host-cell actin filament assembly generated by the Arp2/3 
complex (Welch et al., 1997; May et al., 1999). We found that CK666 
but not SMIFH2 significantly decreased Listeria velocity (Supple-
mental Figure S1).
We also confirmed that SMIFH2 but not CK666 blocked EMT 
induced by TGF-β in two additional well-characterized clonal cells 
models, NMuMG mouse mammary epithelial cells (Miettinen 
et al., 1994; Bhowmick et al., 2001; Lamouille and Derynck, 2007; 
Haynes et al., 2011), and HK2 human kidney epithelial cells (Jeon 
et al., 2015; Rana et al., 2015). EMT in NMuMG cells includes re-
modeling of actin filaments into stress fibers (Figure 2A), delocal-
ization of E-cadherin from cell–cell contacts, and decreased E-cad-
herin expression (Figure 2, A–C) and increased fibronectin 
expression (Figure 2, B and D). Characteristics of EMT in HK2 cells 
include increased expression of N-cadherin and Snail (Figure 2, 
E–G). These well characterized markers of EMT in both cell types 
were significantly blocked by SMIFH2 but not CK666 (Figure 2, 
A–G), which with our data for A549 cells indicate that inhibiting 
activity of formins but not the Arp2/3 complex prevents both mor-
phological and transcriptional programs of EMT in distinctly differ-
ent types of epithelial cells.
FIGURE 2: SMIFH2 but not CK666 blocks EMT of NMuMG and HK2 cells with TGF-β. (A–D) NMuMG cells maintained 
in the absence (−) or presence (+) of TGF-β without and with SMIFH2 or CK666 for 48 h were immunolabeled for 
E-cadherin and stained for F-actin with rhodamine–phalloidin (A) (bar, 20 μm) and lysates immunoblotted for E-cadherin, 
fibronectin, and α-tubulin (B). Semiquantitative densitometry of immunoblots described in B probed for E-cadherin (C); 
fibronectin (D) determined from four separate cell preparations. (E–G) Lysates of HK2 cells maintained as described for 
NMuMG cells immunoblotted for N-cadherin (E, F) and Snail (E, G) with semiquantitative densitometry determined from 
four separate cell preparations. In C, D, F, and G, boxes show the median ± 95% confidence intervals with whiskers 
indicating smallest and largest values.
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FIGURE 3: SMIFH2 but not CK666 blocks increased pSmad2 with TGF-β. (A) Immunoblots of 
lysates from A549 cells maintained for 48 h in the absence (−) or presence (+) of TGF-β for 
48 h without (DMSO) or with SMIFH2 or CK666 probed for phosphorylated Smad2 (pSmad2), 
total Smad2, E-cadherin, and α-tubulin. (B) Semiquantitative densitometry of immunoblots 
probed for pSmad2 as shown in A from four independent cell preparations. Boxes show the 
median ± 95% confidence intervals with whiskers indicating smallest and largest values. 
(C) Confocal images of A549 cells maintained for 48 h in the absence (−) or presence (+) of 
TGF-β for 48 h without (DMSO) or with SMIFH2 or CK666 immunolabeled for Smad2 (green) 
and costained with DAPI for nuclei (blue) and rhodamine–phalloidin for actin filaments 
(magenta). Bar, 20 μm. (D) Nuclear to cytoplasmic ratio of Smad2 from immunolabeling as 
shown in C quantified for 36–48 cells per condition from three independent cell preparations. 
(E) Immunoblots of lysates from HK2 cells maintained in the absence (−) or presence (+) of 
TGF-β for 48 h without (DMSO) or with SMIFH2 or CK666 probed for pSmad2 and total 
Smad2. (F) Semiquantitative densitometry of pSmad2 immunoblots as shown in E from three 
independent cell preparations.
Formin activity is necessary for 
phosphorylation of Smad2 with TGF-β
The ability of SMIFH2 to block morphologi-
cal and transcription changes with EMT sug-
gested it might act at a proximal step in 
TGF-β signaling. Consistent with this predic-
tion, we found that increased phosphoryla-
tion of Smad2 (S465/467; pSmad2) in A549 
cells treated with TGF-β for 48 h was 
blocked by SMIFH2 but not CK666 (Figure 
3, A and B). Total Smad2 was unchanged in 
the absence or presence of TGF-β or inhibi-
tors. Phosphorylated Smad2, an initial effec-
tor of the activated TGF-β receptor, forms a 
complex with other Smad proteins and 
translocates to the nucleus to complex with 
transcription regulators repressing or acti-
vating target genes such as E-cadherin, 
Snail, and fibronectin (Heldin and Mousta-
kas, 2012; Lamouille et al., 2014). To score 
for nuclear Smad2 we immunolabeled A549 
cells with antibodies to total Smad2 be-
cause available pSmad2 antibodies are not 
effective for immunolabeling and stained 
nuclei with 4’,6-diamidino-2-phenylindole 
(DAPI) and actin filaments with rhodamine-
phalloidin. We confirmed an increase in the 
nuclear-to-cytoplasmic ratio of Smad2 after 
48 h with TGF-β in dimethyl sulfoxide 
(DMSO) controls that was inhibited by 
SMIFH2 but not CK666 (Figure 3, C and D). 
The nuclear-to-cytoplasmic ratio of Smad2 
in the absence of TGF-β was similar in con-
trol cells and cells treated with SMIFH2 or 
CK666 (Figure 3, C and D). We also con-
firmed an increase in pSmad2 in DMSO 
control HK2 cells treated with TGF-β for 48 
h that was blocked by SMIFH2 but not CK66 
(Figure 3 E and F). These data with two dif-
ferent EMT cell models, human lung alveo-
lar A549 cells and kidney HK2 cells, indicate 
formin activity is necessary for the proximal 
TGF-β signaling event of increased pS-
mad2, which to our knowledge has not 
been previously reported.
To further test formin-dependent 
pSmad2, we determined acute (≤60 min) 
compared with longer-term (48 h) responses 
to TGF-β. In DMSO controls of A549 cells, 
pSmad2 increased between 10 and 60 min 
with TGF-β, determined by immunoblotting 
cell lysates (Figure 4, A and B). Additionally, 
immunolabeling for total Smad2 indicated 
increased nuclear localization at 60 min after 
adding TGF-β (Figure 4, C and D). Both of 
these responses were completely blocked 
by SMIFH2 (Figure 3, A–D), indicating a 
necessary role for formin activity in rapid 
as well as longer-term TGF-β signaling. 
However, when we added SMIFH2 30 min 
after ligand treatment, the abundance of 
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pSmad2 decreased to only 50% of DMSO controls, compared with 
being nearly abolished when the inhibitor was added at the same 
time as ligand (Supplemental Figure S2A). These findings suggest 
initial signaling to pSmad2 is fully dependent on formin activity but 
only partially dependent after the signal is initiated. Additionally, we 
confirmed that Smad2 phosphorylation and nuclear translocation 
are dependent on an intact actin cytoskeleton by treating cells with 
latrunculin, which binds G-actin and disrupts actin filament assem-
blies. Pretreating A549 cells with 5 μM latrunculin for 15 min before 
FIGURE 4: Inhibiting formin activity but not actomyosin contractility blocks increased pSmad2 
with TGF-β. (A) Immunoblots of lysates from A549 cells maintained in the absence (−) or 
presence (+) of TGF-β without (DMSO control) or with SMIFH2 for the indicated times probed 
for pSmad2 and β-actin. (B) Semiquantitative densitometry of immunoblots for pSmad described 
in A at 60 min from five independent cell preparations. Boxes show the median ± 95% 
confidence intervals with whiskers indicating smallest and largest values. (C) Confocal images 
A549 cells immunolabeled for Smad2 (green) and costained with DAPI for nuclei (blue) and 
rhodamine–phalloidin for actin filaments (magenta). Bar, 20 μm. (D) Nuclear to cytoplasmic ratio 
of Smad2 from immunolabeling as shown in C. Data were obtained from 35 to 45 cells per 
condition from three independent cell preparations. (E) Immunoblots of lysates from A549 cells 
maintained in the absence (−) or presence (+) of TGF-β for 48 h without (DMSO) or with 
SMIFH2, CK666, Blebbistatin, or Y-27632 probed with for fibronectin, E-cadherin, pSmad2, total 
Smad2, Snail, pMLC, and β−actin. Data are representative of two independent cell preparations. 
(F) Confocal images of the A549 cells with the indicated treatments and stained with 
rhodamine–phalloidin to visualize actin filaments. Images show maximum-intensity projections 
of multiple Z-sections and are representative of two separate cell preparactions. Bar, 20 μm.
adding TGF-β significantly decreased the 
abundance of pSmad (Supplemental Figure 
S2, B and C) compared with DMSO controls 
and blocked nuclear translocation of Smad2 
(Supplemental Figure S2D). These findings 
conflict with a recent report that the actin 
filament disrupting drugs cytochalasin and 
latrunculin do not inhibit increased pSmad2 
in renal tubular epithelial cells treated with 
TGF-β (Muehlich et al., 2017).
To determine how formin activity might 
be necessary for increased pSmad2 with 
TGF-β we first tested actomyosin contractil-
ity, which is increased by formin activity, and 
we found that in A549 cells pMLC increased 
with TGF-β in DMSO controls but not in the 
presence of SMHFH2 (Figure 1C). We 
treated A549 cells with Y-27632, which inhib-
its Rho-kinase activity, and with blebbistatin, 
which inhibits myosin ll activity. Neither in-
hibitor blocked the increase in pSmad2 with 
TGF-β, the decrease in E-cadherin or the in-
crease in Snail or fibronectin (with markedly 
more fibronectin with Y-27632 compared 
with DMSO controls) (Figure 4E). This lack of 
blocking increased pSmad2 was despite the 
efficacy of the inhibitors, which we con-
firmed. Y-27632 blocked the increase in 
pMLC (Figure 4E) and Y-27632 and blebbi-
statin both prevented the assembly of actin 
stress fibers with EMT (Figure 4F).
To further test a mechanism for formin-
dependent pSmad, we next asked whether 
SMIFH2 alters the plasma membrane ex-
pression or dimerization of TGF-β recep-
tors. TGF-β signaling is initiated by ligand 
binding to the type 2 receptor (TGF-βR2), 
which phosphorylates and dimerizes with 
the type 1 receptor (TGF-βR1). Kinase ac-
tivity of TGF-βR1 phosphorylates Smad2 
(Heldin and Moustakas, 2012). Accord-
ingly, TGF-β signaling is dependent on the 
abundance of TGF-βR1 and TGF-βR2 at 
the plasma membrane as well as their di-
merization and intracellular trafficking 
(Chen, 2009; Huang and Chen, 2012; Gan-
guly et al., 2015). To test whether SMIFH2 
affects the abundance of TGF-βR1 at the 
plasma membrane we biotinylated A549 
cells stably expressing the receptor 
tagged with a Flag epitope, immunopre-
cipitated biotinylated proteins, and immu-
noblotted immune complexes with Flag 
antibodies. SMIFH2 had no effect on the abundance of TGF-βR1 
in the absence of TGF-β or on the ligand-induced decrease in cell 
surface expression of TGF-βR1 seen with DMSO controls at 30 
and 60 min (Figure 5A), suggesting that cell surface expression 
and the dynamics of TGF-βR1 are not dependent on formin activ-
ity. We also found that SMIFH2 had no observable effect on TGF-
βR1 and TGF-βR2 dimerization with TGF-β. A549 cells transiently 
coexpressing TGF-βR1 tagged with a Myc epitope and TGF-βR2-
Flag were treated with TGF-β and Flag immune complexes from 
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cell lysates were immunoblotted with Myc antibodies. There was 
no difference in the abundance of coprecipitated TGF-βR1 in the 
absence or presence of SMIFH2 (Figure 5B). Additionally, SMIFH2 
had no effect on the abundance of endogenous Smad2 copre-
cipitating with TGF-βR1-Flag stably expressed in A549 cells after 
TGF-β treatment (Figure 5C).
Consistent with SMIFH2 not blocking receptor membrane 
abundance or dimerization, we found that the inhibitor also did 
not block nuclear translocation of the Hippo signaling protein 
TAZ with TGF-β. TAZ and the Yes-associated protein YAP are 
transcriptional coactivators mediating effects of Hippo signaling 
for cell differentiation and tissue homeostasis. Although cross-
talk between TGF-β signaling and TAZ/YAP is recognized, the 
precise regulatory mechanisms remain unresolved and are likely 
dependent on cell type and context (Hansen et al., 2016). In 
A549 cells treated with TGF-β for 60 min, both DMSO control 
cells and cells treated with SMIFH2 had a significant increase in 
the TAZ nuclear to cytoplasmic ratio. In addition to further sug-
gesting that SMIFH2 does not affect signaling at the level of the 
TGF-β receptor, these findings confirm that nuclear translocation 
of TAZ is independent of pSmad2 and also the specificity of 
SMIFH2 effects, which our data suggest are selective for 
TGF-β receptor activation of Smad2 but not for cross-talk with 
TAZ.
FIGURE 5: SMIFH2 does not decrease plasma membrane abundance or dimerization of TGF-β 
type 1 receptor or nuclear translocation of TAZ in A549 cells. (A) Cells stably expressing 
Flag-tagged TGF-β R1 were treated with TGF-β in the absence (DMSO) or presence of SMIFH2 
for the indicated times. Cell surface expression of TGF-β R1-Flag was determined by 
immunoblotting neutravidin complexes from biotinylated cells. (B) Immunoblots with antibodies 
to Myc and Flag of total lysates and Flag immune complexes from cells transiently expressing 
TGF-β R1-Myc and TGF-β R2-Flag. Cells were treated with TGF-β for the indicated times in the 
absence (DMSO) or presence of SMIFH2 before lysis. (C) Immunoblots with antibodies to Flag 
and Smad2 of Smad2 immune complexes from cells stably expressing TGF-β R1-Flag and 
treated for 15 min with TGF-β in the absence (DMSO) or presence of SMIFH2. (D) Confocal 
images of cells maintained in the absence (−) or presence (+) of TGF-β for 60 min without 
(DMSO) or with SMIFH2 immunolabeled for TAZ (green) and costained with DAPI for nuclei 
(blue) and rhodamine–phalloidin for actin filaments (magenta). Bar, 20 μm. (E) Nuclear to 
cytoplasmic ratio of TAZ from immunolabeling as shown in C quantified for 30–35 cells per 
condition from two independent cell preparations.
DIAPH1 and DIAPH3 are necessary 
for EMT with TGF-β
We next sought to identify the formin(s) 
necessary for TGF-β signaling and EMT, 
which would also validate formin-selective 
effects of SMIFH2. Nearly all of the 15 
mammalian formins are expressed in epi-
thelial cells of different tissue origins 
(Krainer et al., 2013). We infected cells with 
lentivirus expressing formin-specific shRNA 
sequences and used nontargeting shRNA 
for controls. However, because antibodies 
to some formins are not available, we were 
limited to confirming suppressed expres-
sion of seven formins: DIAPH (1-3), DAAM1, 
FHOD1, FMNL1, and Formin1 (Supple-
mental Figure S3, A and B). Formin1 ex-
pression but not the expression of other 
formins decreased with 48 h of TGF-β 
treatment. In A549 cells, none of the indi-
vidual formin shRNA we tested blocked 
increased pSmad2 or down-regulation of 
E-cadherin with TGF-β (Figure 6A and Sup-
plemental Figure S3B). However, FHOD1 
shRNA but not shRNA for other formins 
blocked the morphological program of 
changes in cell morphology and acquisi-
tion of actin stress fibers (Figure 6B), which 
is consistent with previous reports that 
FHOD1 is necessary for morphological 
transitions but not transcriptional events 
with EMT (Jurmeister et al., 2012; Gard-
berg et al., 2013). The specificity of FHOD1 
shRNA blocking actin stress fiber assembly 
was confirmed by rescue with heterolo-
gously expressed full-length GFP-FHOD1 
resistant to the shRNA (Supplemental 
Figure S3C).
In contrast with our finding with A549 cells, however, in HK2 cells 
shRNA for either DIAPH1 or DIAPH3 but not other formins signifi-
cantly blocked the increase in pSmad, Snail, and N-cadherin with 
TGF-β compared with control NT cells (Figure 6, C–E). Respective 
shRNA sequences decreased expression of DIAPH1 and 2 (Figure 
6C) and DIAPH 3 (Supplemental Figure S3D). Consistent with find-
ings in A549 cells, FHOD1 shRNA did block increased pSmad2 
(Supplemental Figure S3E). These data suggested the possibility of 
redundancy between DIAPH family formins in A549 cells, which we 
confirmed by using pooled shRNA to suppress formin family mem-
bers in A549 cells. We confirmed specificity of DIAPH knockdown 
by immunoblotting with specific antibodies (Supplmental Figure 
S4A) and found that pooled shRNA targeting DIAPH1, 2, and 3 but 
not pooled shRNA for FMNL1 and 2 attenuated increased pSmad2 
and Snail after 48 h with TGF-β (Figure 7, A–C), although these re-
sponses were not completely blocked as in HK2 cells. Compared 
with control NT shRNA, DIAPH1-3 pooled shRNA also attenuated 
the abundance of ventral actin stress fibers after 48 with TGF-β  
(Figure 7D), and actin filament abundance was in part rescued with 
heterologously expressed mouse GFP-DIAPH3 but not GFP alone, 
consistent with redundancy between DIAPH1 and 3 (Supplemental 
Figure S4). Additionally, in A549 cells, pooled shRNA for DIAPH1, 2, 
and 3 but not for DAMM 1 and 2 attenuated acute increases in pS-
mad2 with TGF-β between 10 and 60 min (Figure 7E). These data 
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indicate cell-specific effects of DIAPH family formins in TGF-β sig-
naling, with DIAPH1 or DIAPH3 independently being necessary in 
HK2 cells but redundancy of these two formins in A549 cells.
DISCUSSION
Despite substantial remodeling of actin filaments and changes in 
cell shape during EMT, little is known about how this morphological 
program for EMT is regulated compared with the well-studied EMT 
transcription program (Xu et al., 2009). One key finding of our study 
is that actin nucleation by formins but not the Arp2/3 complex is 
necessary for both morphological and transcription programs driv-
ing EMT in response to TGF-β, which we confirmed for three distinct 
epithelial cell types; human A549 lung alveolar and HK2 kidney epi-
thelial cells and mouse NMuMG mammary epithelial cells. Inhibiting 
formin activity with the broad-spectrum formin inhibitor SMIFH2 
FIGURE 6: Formin-selective shRNA to test effects on EMT by TGF-β. (A) Immunoblots of lysates 
of A549 cells infected with lentivirus containing nontargeting (NT) or the indicated formin-
selective shRNA, maintained in the absence (–) or presence (+) of TGF-β for 48 h and probed for 
pSmad2, E-cadherin, and α-tubulin. Blots are representative of two independent cell 
preparations. (B) Confocal images of A549 cells expressing the indicated formin shRNA and 
labeled for actin filaments with rhodamine–phalloidin. Images are representative of three 
independent cell preparations and show maximum-intensity projections of multiple Z-sections. 
Bar, 20 μm. (C) Immunoblots of lysates of HK2 cells infected with lentivirus containing NT or the 
indicated formin-selective shRNA, maintained in the absence (–) or presence (+) of TGF-β for 48 
h and probed for pSmad2, Snail, N-cadherin, DIAPH1 and DIAPH 2, and α-tubulin. 
(D, E) Semiquantitative densitometry of immunoblots described in C probed for pSmad (D) and 
Snail (E) obtained from three independent cell preparations.
(Rizvi et al., 2009), but not Arp2/3 complex 
activity with the selective inhibitor CK666 
(Nolen et al., 2009), not only blocked a mes-
enchymal morphology and acquisition of 
actin stress fibers but also decreased ex-
pression of E-cadherin and increased ex-
pression of fibronectin and Snail. In contrast 
to our findings, WASP-interacting protein 
(WIP), a regulator of nuclear promoting fac-
tors activating the Arp2/3 complex, was re-
ported to be necessary for the morphologi-
cal program of EMT (Salvi and Thanabalu, 
2017); however, WIP is not necessary for the 
transcriptional programs of deceased E-
cadherin or increased N-cadherin, which we 
found are blocked by SMIFH2. Using shRNA 
to different formin family members, we de-
termined that FHOD1 shRNA blocked a 
mesenchymal morphology and actin stress 
fibers with EMT of A549 cells but had no 
effect on the transcriptional programs for 
decreased E-cadherin or increased fibronec-
tin and Snail. These data are consistent with 
previous findings showing that FHOD1 is 
necessary for a mesenchymal morphology 
and assembly of actin stress fibers but not 
down-regulation of E-cadherin with TGF-β–
induced EMT of clonal MDA-MB-231 hu-
man breast cancer cells (Jurmeister et al., 
2012; Gardberg et al., 2013). In contrast, we 
found that shRNA to DIAPH1 and DIAPH 3 
blocked proximal TGF-β signaling at the 
level of pSmad and hence both morpho-
logical and transcriptional EMT programs.
Our second key finding with broad im-
pact beyond EMT is that inhibiting formin 
activity blocks increased pSmad2 by TGF-β, 
a critical initial step in TGF-β signaling for 
reprogramming of gene expression. These 
findings are in contrast to a previous report 
that SMIFH2 does not block increased 
pSmad2 during human myofibroblast differ-
entiation with TGF-β (Sandbo et al., 2013). 
The formin FMNL2 was found to be neces-
sary for efficient EMT of a metastatic line of 
SW480 clonal colon adenocarcinoma cells 
treated with TGF-β (Li et al., 2010), with 
FMNL2 siRNA partially but not completely suppressing decreased 
expression of E-cadherin and increased phosphorylation of Smad3. 
However, this study found no effect on increased abundance of 
Snail, and FMLN2-dependent changes in actin filament remodeling 
and acute TGF-β signaling (<24 h) were not determined. Our data 
show that inhibiting formin activity with SMIFH2 blocks acute (10–
60 min) and sustained (48 h) increases in pSmad2 and the nuclear 
translocation of Smad2 but has no effect on Smad2 expression, the 
cell surface expression and dimerization of TGF-β receptors, or the 
association of Smad2 with TGF-βR1. Moreover, we found that shRNA 
for formins DIAPH1 and DIAPH 3 phenocopied blocking increased 
pSmad2 and Snail that we found with SMIFH2. Additionally, we 
found that intact actin filament network, which we disrupted with 
latrunculin, is necessary for increased pSmad2 and nuclear translo-
cation of Smad2 with TGF-β. Vasodilator-stimulated phosphoprotein 
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(VASP), a regulator of actin cytoskeleton remodeling, was recently 
shown to be necessary for targeting and maintaining TGF-βR2 to the 
plasma membrane (Tu et al., 2015); however, our data with biotinyl-
ated cells showing no effect of SMIFH2 on the cell surface expres-
sion of TGF-βR1 suggest that this is not a mechanism for formin-
dependent TGF-β signaling. Additionally, we predict that formins 
likely do not suppress negative regulation of TGF-β signaling by 
Smad7 (Shi et al., 2004). Smad7 forms a stable complex with TGF-
βR1 to inhibit Smad phosphorylation and receptor-Smad associa-
tion; however, inhibiting formin activity had no effect on the abun-
dance of Smad2 coprecipitating with TGF-βR1. Moreover, although 
SMIFH2 blocked increased pMLC with EMT, increased pSmad likely 
does not require formin-dependent actomyosin contractility be-
cause inhibiting contractility by blocking Rho-kinase or myosin II ac-
tivity did not prevent increased pSmad with TGF-β.
Another important finding is that although inhibiting formin ac-
tivity with SMIFH2 blocks increased pSmad2 and nuclear transloca-
tion of Smad2 with TGF-β, it does not block nuclear translocation of 
TAZ. These data confirm, first, that SMIFH2 does not block the fidel-
ity of signaling by TGF-β receptors; second, the specificity of 
SMIFH2 for preventing increased pSmad; and, third, the recently 
reported finding that TGF-β regulation of TAZ is independent of 
Smads (Miranda et al., 2017). One possibility for formin-dependent 
TGF-β signaling that is not currently feasible to experimentally test 
is whether actin filaments maintain a structural conformation of the 
TGF-βR1 necessary for increased pSmad2 but not for dimerizing 
with TGF-βR2 or activating TAZ.
Further investigation is warranted to determine how formin activ-
ity regulates pSmad2. One possibility is that formin-dependent ac-
tin architectures maintain a structural conformation of the TGF-βR1 
necessary for kinase activity or for signal relay to Smad2 but not for 
TGF-βR1 and TGF-βR2 dimerization, the association of Smad2 with 
TGF-βR1, or the nuclear translocation of TAZ. An intriguing question 
that to our knowledge remains unanswered is whether TGF-β recep-
tors are anchored to actin filaments, possibly through binding linker 
proteins such as the ERM family members ezrin, radixin, and moesin 
or through NHERF, as has been shown for receptor tyrosine kinases 
(Maudsley et al., 2000; Karthikeyan et al., 2002; Demoulin et al., 
2003) and G protein-coupled receptors (Hall et al., 1998; Cao et al., 
1999; Li et al., 2002; Heydorn et al., 2004). Possible actin anchoring 
by TGF-β receptors is suggested by recent findings that the closely 
related type II bone morphogenic protein receptor scaffolds the ac-
tin cytoskeleton (Podkowa et al., 2013). Another possibility is that 
formin-dependent actin architectures maintain TGF-β receptors in 
specialized membrane domains necessary for Smad2 phosphoryla-
tion. Consistent with this possibility, actin filaments regulate the or-
ganization and mobility of membrane proteins for downstream sig-
naling (Mattila et al., 2016) and TGF-β–induced Smad activation 
requires sequestration of receptors from caveolin-associated to 
clathrin-coated pits (Razani et al., 2001; Penheiter et al., 2002; Di 
Guglielmo et al., 2003; Muthusamy et al., 2015). Additionally, recent 
findings indicate that mechanical tension spatially segregates TGF-β 
receptors at the plasma membrane, with TGF-βR1 sequestered at 
integrin-rich focal adhesions but TGF-βR2 being excluded from 
these sites (Rys et al., 2015). Hence, formin-dependent actin archi-
tectures could regulate differential partitioning of TGF-β receptor 
complexes at the cell surface.
Our findings indicate that DIAPH1 and DIAPH 3 are necessary for 
TGF-β signaling, with redundancy in A549 cells but not in HK2 cells. 
However, we cannot rule out an important role for additional formins 
in TGF-β signaling or EMT in other cell types. As discussed above, 
FMNL expression is necessary for TGF-β–induced EMT of clonal 
FIGURE 7: Pooled DIAPH123 shRNA inhibits TGF-β signaling in A549 cells. (A) Immunoblots of lysates from A549 cells 
infected with pooled formin shRNA and maintained in the in the absence (–) or presence (+) of TGF-β for 48 h probed 
for pSmad2 (S465/467), Snail, and α-tubulin. (B, C) Semiquantitative densitometry of immunoblots described in A for 
pSmad (B) and Snail (C) obtained from three independent cell preparations. (D) Images of A549 cells infected with 
lentivirus containing NT shRNA or DIAPH123 pooled shRNA and maintained in the absence (−) or presence (+) of TGF-β 
for 48 h stained for F-actin with rhodamine–phalloidin. Bar, 20 μm. (E) Representative immunoblots of two separate 
preparations of lysates from A549 cells expressing NT shRNA and pooled shRNA for DIAPH1, -2, and -3 and for DAAM1 
and -2 and then treated with TGF-β for the indicated times and probed for pSmad2 (S465/467) and α-tubulin.
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metastatic colon adenocarcinoma cells, including the transcriptional 
program for decreased E-cadherin. Formins have been shown to 
regulate gene transcription, most notably by increasing activity of 
serum response factor (SRF) (Gasteier et al., 2003; Westendorf and 
Koka, 2004; Xie et al., 2008; Jurmeister et al., 2012) or promoting 
nuclear translocation of myocardin-related transcription factor 
(MRTF), an SRF coactivator (Baarlink et al., 2013). Moreover, nuclear 
translocation of MRTF is necessary for TGF-β–induced EMT (Korol 
et al., 2016; O’Connor et al., 2016) by regulating the morphological 
EMT program (O’Connor and Gomez, 2013)
Taken together, our findings on formin-dependent EMT have 
clinical significance for diseases such as cancer metastasis and fibro-
sis, which rely on epithelial transdifferentiation. And, importantly, 
our findings on formin-dependent TGF-β signaling have broad sig-
nificance for understanding and for possible therapeutic insights on 
the myriad of normal and disease behaviors regulated by TGF-β.
MATERIALS AND METHODS
Cell culture and treatments
Clonal human lung A549 adenocarcinoma cells (obtained from Har-
old Chapman, University of California, San Francisco [UCSF]) were 
cultured in DMEM (4.5 g/l glucose) supplemented with 10% fetal 
bovine serum (FBS) (Invitrogen), 100 U/ml penicillin, and 100 μg/ml 
streptomycin as described previously (Haynes et al., 2011; Rana 
et al., 2015). For EMT, A549 cells were maintained in serum-free 
small airway basal medium (Lonza, Basel, Switzerland). Human HK2 
cells (American Type Cell Collection) were maintained in DMEM 
with Hams F-12 containing 4.5 g/l glucose and supplemented with 
10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin. For 
EMT, HK2 cells were maintained in serum- and Ca2+-free keratino-
cyte medium (Invitrogen) supplemented with 25 mg/ml bovine pitu-
itary extract and 0.2 ng/ml epidermal growth factor (EGF), as de-
scribed previously (Rana et al., 2015). NMuMG normal mouse 
mammary gland epithelial cells (obtained from R. Derynck, UCSF) 
were maintained in DMEM containing 4.5 g/l glucose and supple-
mented with 10% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 
and 10 μg/ml insulin (Sigma-Aldrich) as described previously 
(Haynes et al., 2011). EMT was induced by adding recombinant 
TGF-β (PeproTech, Rocky Hill, NJ), using 10 ng/ml for HK2 cells and 
5 ng/ml for A549 and NMuMG cells. Pharmacological inhibitors 
SMIFH2 (Sigma-Aldrich) and CK666 (Calbiochem) were dissolved in 
DMSO. Unless otherwise indicated, DMSO (control), SMIFH2 (25 
μM), and CK666 (80 μM) were added at the time of TGF-β treat-
ment and maintained in the medium for 48 h. 293FT cells used for 
generating lentivirus were maintained DMEM containing 4.5 g/l 
glucose and supplemented with 10% FBS, 100 U/ml penicillin, and 
100 μg/ml streptomycin and NEAA. All cell lines were maintained at 
37°C in 5% CO2.
DNA constructs, lentivirus production, and transfections
For transient expression, A549 cells were transfected with pRK5 
containing TGF-βR1-Myc (provided by Tamara Alliston, UCSF) or 
TGF-βR1-Flag (provided by R. Derynck, UCSF), pEGFP-C2 (Clone-
tech) containing full-length GFP-FHOD1 (provided by Stefan Linder, 
Universitätsklinikum Hamburg), or mEmerald-C1 containing mouse 
mDia3 (Addgene) using Lipofectamine 2000 (Invitrogen) according 
to the manufacturer’s specifications. The lentiviral plasmids pLKO.1-
puro containing shRNA sequences to human DIAPH1 (NM_005219; 
CCGGGCCCAGAATCTCTCAACTTTCTCGAGAAAGATTGAGA-
GATTCTGGGCTTTTT), DIAPH2 (NM_006729; CCGGCCTACAAAG-
AAGAAAGTGAAACTCGAGTTTCACTTTCTTCTTTGTAG-
GTTTTTG), DIAPH3 (NM_030932; CCGGCGTGTCAGAATAGCTA-
AAGAACTCGAGTTCTTTAGCTATTCTGACACGTTTTTTG), 
DAAM1 (NM_014992; CCGGGCACAATACTATCTCCTGAAACTCG-
AGTTTCAGGAGATAGTATTGTGCTTTTTG), DAAM2 (NM_015345; 
CCGGGCTCTTATTCAATACCACGTTCTCGAGAACGTGGTATT-
GAATAAGAGCTTTTTTG), FHOD1 (NM_013241; CCGGAGGT-
GCTGTATCCCGGAAATCCTCGAGGATTTCCGGGATACAG-
CACCTTTTTTG), FMNL2 (NM_052905; CCGGGCCAAGCAGAA-
GAACTCTGAACTCGAGTTCAGAGTTCTTCTGCTTGGCTTTTT), 
and Formin1 (NM_005892; CCGGATATTGGACTAGGATACAAA TC
TCGAGATTTGTATCCTAGTCCAATATTTTTTG) were obtained from 
Sigma-Aldrich (MISSION shRNA) as was MISSION Non-Target 
shRNA Control Vector. Lentivirus was produced in 293FT packaging 
cells using the Virapower Packaging System (Invitrogen) according 
to the manufacturer’s protocol. A549 and HK2 cells were infected 
with lentivirus expressing control or formin shRNA in growth me-
dium supplemented with 4 μg/ml Sequabrene (Sigma-Aldrich). Sta-
ble clonal cell lines were selected with 5 μg/ml puromycin (Cellgro; 
Mediatech, Manassas, VA) and maintained in 2.5 μg/ml puromycin. 
Retroviral plasmid LNCX TGF-βR1-Flag (obtained from Rik Derynck) 
was expressed in 293T Ampho cells with packaging plasmid PCL-
Ampho for infection of A549 cells in growth medium supplemented 
with 4 μg/ml Sequabrene (Sigma-Aldrich). Stable A549 clones ex-
pressing TGF-βR1-Flag were selected and maintained in the antibi-
otic G418 (Life Technologies).
Immunolabeling, staining, and image acquisition
For immunolabeling, cells plated on acid-washed glass coverslips 
were washed at the indicated times in phosphate-buffered saline 
(PBS), fixed with 4% formaldehyde for 15 min, permeabilized with 
0.2% Triton X-100 for 5 min, incubated with 5% horse serum and 1% 
bovine serum albumin (BSA) in PBS for 1 h, and then incubated with 
antibodies for E-cadherin (for A549 cells, 1:500, Invitrogen; for 
NMuMG cells, 1:200, BD Transduction Laboratories), Smad2 (1:200, 
Cell Signaling), or TAZ (1:200, Sigma) overnight at 4°C. The cover-
slips were washed with PBS and then incubated for 1 h at room 
temperature (RT) with Alexa-Fluor-488–conjugated secondary anti-
bodies (Invitrogen). Actin filaments were labeled with rhodamine–
phalloidin (1:500; Invitrogen) added during secondary antibody in-
cubations. Nuclei were labeled with DAPI (1:10,000) added during 
the final wash after immunolabeling. Coverslips were mounted on 
slides with ProLong Gold antifade reagent (Invitrogen). Cells were 
imaged using a 60X Plan Apochromat TIRF 1.45 NA oil immersion 
objective on an inverted microscope system (Nikon Eclipse TE2000 
Perfect Focus System; Nikon Instruments, Melville, NY) equipped 
with a spinning-disk confocal scanner unit (CSU10; Yokogawa, 
Newnan, GA), a 488-nm solid-state laser (LMM5; Spectral Applied 
Research), a multipoint stage (MS-2000; Applied Scientific Instru-
ments), a CoolSnap HQ2 cooled charge-coupled camera (Photo-
metrics,) and camera-triggered electronic shutters controlled with 
NIS-Elements Imaging Software (Nikon). Images were processed 
using NIS-Elements and rhodamine–phalloidin fluorescence was 
quantified using images processed using the ImageJ automated fil-
ter “Find Edges.” Briefly, this algorithm uses a Sobel edge detection 
operator to highlight sharp changes in intensity using two 3 × 3 
convolution kernels that generate vertical and horizontal derivatives 
of pixel values. The final processed image features enhanced edges 
produced by combining the two derivatives using the square root 
sum of the squares.
Immunoblotting, biotinylation, and Immunoprecipitation
For immunoblotting, cells were lysed in RIPA buffer (50 mM Tris-HCl, 
pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM vanadate, 1 mM NaF, 
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1% Triton X-100, 0.1% deoxycholate, supplemented with protease 
inhibitor tablets). After centrifuging lysates at 12,000 rpm for 5 min 
to obtain a postnuclear supernatant, proteins were separated by 
SDS–PAGE and transferred onto polyvinylidene difluoride (PVDF) 
membranes (Millipore, Haywood, CA) as previously described 
(Haynes et al., 2011; Rana et al., 2015). Membranes were blocked 
with 5% nonfat milk or 5% BSA and incubated with primary antibod-
ies for 1 h at RT or overnight at 4°C. Primary antibodies included fi-
bronectin, Flag-M2, α-tubulin, FHOD1, and DIAPH2 (Sigma-Al-
drich), pSmad2 (S465/467), Smad2, Snail, pMLC-Thr18/ Ser19 (Cell 
Signaling Technologies), E-cadherin (BD Transduction Labs), β-actin 
(Santa Cruz), and DIAPH1, DIAPH3, FMNL1, and DAAM1 (Protein-
tech Inc). After washing, membranes were incubated with horserad-
ish peroxidase–conjugated secondary antibodies (Bio Rad Labora-
tories) for 1 h at room temperature and immunoreactivity visualized 
with enhanced femtochemiluminescence (Thermo Scientific) and 
imaged using a BioRad Chemidoc XRS. BioRad Chemidoc XRS Im-
age Lab software was used for semiquantitative densitometric anal-
ysis of immunoblots. Prism software was used for plotting data and 
statistical analysis.
Variations of the above protocol included assays using biotinyl-
ation and immunoprecipitation. Cell surface expression of TβRI was 
determined by biotinylating cells and isolating cell surface biotinyl-
ated proteins using a commercially available kit (Pierce Cell Surface 
Protein Isolation kit; Thermo Fisher Scientific). A549 cells were bioti-
nylated on ice for 30 min and lysed. Biotinylated proteins were iso-
lated and probed by immunoblotting with antibodies to TβRI-Flag. 
For immunprecipitation, cell lysates were prepared in RIPA buffer as 
described for immunoblotting and then inclubated with anti-Flag-
M2 magnetic beads (Sigma-Aldrich; cat. no. M8823) overnight at 
4°C. The beads were washed three times and boiled in sample buf-
fer for 5 min. Proteins in immune complexes were separated by 
SDS–PAGE for immunoblotting as described above.
Listeria monocytogenes motility in host cells
CCL39 fibroblasts stably expressing Lifeact-GFP were plated in Mat-
Tek dishes and incubated for 8–10 h with L. monocytogenes ex-
pressing mCherry-ActA (provided by Anna Bakardjiev, UCSF). Cells 
were washed 2× with PBS prior to time-lapse imaging using the mi-
croscopy unit described above for image acquisition. Velocity of 
moving Listeria was measured by using NIS-Elements Imaging Soft-
ware by tracking displacement length as a function of time.
ACKNOWLEDGMENTS
We thank members of the Barber and Wittmann labs for construc-
tive discussions. We thank Rik Derynck, Tamara Alliston, Hal Chap-
man, and Stefan Linder for providing reagents. We also thank B. P. 
Muthusamy and Koy Sateurn in the Derynck lab and David Mon-
teiro in the Alliston lab for technical advice. This work was sup-
ported by National Institutes of Health grant GM116384 to D.L.B. 
and Todd Nystul.
REFERENCES
Baarlink C, Wang H, Grosse R (2013). Nuclear actin network assembly by 
formins regulates the SRF coactivator MAL. Science 340, 864–867.
Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, 
Arteaga CL, Moses HL (2001). Transforming growth factor-beta1 medi-
ates epithelial to mesenchymal transdifferentiation through a RhoA-
dependent mechanism. Mol Biol Cell 12, 27–36.
Borok Z, Whitsett JA, Bitterman PB, Thannickal VJ, Kotton DN, Reynolds 
SD, Krasnow MA, Bianchi DW, Morrisey EE, Hogan, BL, et al (2011). 
Cell plasticity in lung injury and repair: report from an NHLBI workshop. 
Proc Am Thorac Soc 8, 215–222.
Cao TT, Deacon HW, Reczek D, Bretscher A, von Zastrow M (1999). A 
kinase-regulated PDZ-domain interaction controls endocytic sorting of 
the beta2-adrenergic receptor. Nature 401, 286–290.
Chen YG (2009). Endocytic regulation of TGF-beta signaling. Cell Res 19, 
58–70.
Cho HJ, Yoo J (2007). Rho activation is required for transforming growth 
factor-beta-induced epithelial-mesenchymal transition in lens epithelial 
cells. Cell Biol Int 31, 1225–1230.
Demoulin JB, Seo JK, Ekman S, Grapengiesser E, Hellman U, Ronnstrand 
L, Heldin CH (2003). Ligand-induced recruitment of Na+/H+-exchanger 
regulatory factor to the PDGF (platelet-derived growth factor) receptor 
regulates actin cytoskeleton reorganization by PDGF. Biochem J 376, 
505–510.
Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana, JL (2003). Distinct 
endocytic pathways regulate TGF-beta receptor signalling and turnover. 
Nat Cell Biol 5, 410–421.
Ganguly A, Tang Y, Wang L, Ladt K, Loi J, Dargent B, Leterrier C, Roy S 
(2015). A dynamic formin-dependent deep F-actin network in axons. 
J Cell Biol 210, 401–417.
Gardberg M, Kaipio K, Lehtinen L, Mikkonen P, Heuser VD, Talvinen K, 
Iljin K, Kampf C, Uhlen M, Grenman R, et al (2013). FHOD1, a formin 
upregulated in epithelial-mesenchymal transition, participates in cancer 
cell migration and invasion. PLoS One 8, e74923.
Gasteier JE, Madrid R, Krautkramer E, Schroder S, Muranyi W, Benichou S, 
Fackler OT (2003). Activation of the Rac-binding partner FHOD1 induces 
actin stress fibers via a ROCK-dependent mechanism. J Biol Chem 278, 
38902–38912.
Goley ED, Welch MD (2006). The ARP2/3 complex: an actin nucleator 
comes of age. Nature reviews. Mol Cell Biol 7, 713–726.
Goode BL, Eck MJ (2007). Mechanism and function of formins in the control 
of actin assembly. Ann Rev Biochem 76, 593–627.
Hall RA, Ostedgaard LS, Premont RT, Blitzer JT, Rahman N, Welsh MJ, 
Lefkowitz, RJ (1998). A C-terminal motif found in the beta2-adrenergic 
receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance 
regulator determines binding to the Na+/H+ exchanger regulatory fac-
tor family of PDZ proteins. Proc Natl Acad Sci USA 95, 8496–8501.
Hansen CG, Moroishi T, Guan KL (2016) YAP and TAZ: a nexus for Hippo 
signaling and beyond. Trends Cell Biol 25, 499–513.
Haynes J, Srivastava J, Madson N, Wittmann T, Barber DL (2011). Dynamic 
actin remodeling during epithelial-mesenchymal transition depends on 
increased moesin expression. Mol Biol Cell 22, 4750–4764.
Heldin CH, Moustakas A (2012). Role of Smads in TGFbeta signaling. Cell 
Tissue Res 347, 21–36.
Heydorn A, Sondergaard BP, Ersboll B, Holst B, Nielsen FC, Haft CR, 
Whistler J, Schwartz TW (2004). A library of 7TM receptor C-terminal 
tails. Interactions with the proposed post-endocytic sorting proteins 
ERM-binding phosphoprotein 50 (EBP50), N-ethylmaleimide-sensitive 
factor (NSF), sorting nexin 1 (SNX1), and G protein-coupled receptor-
associated sorting protein (GASP). J Biol Chem 279, 54291–54303.
Huang F, Chen YG (2012). Regulation of TGF-beta receptor activity. Cell 
Biosci 2, 9–19.
Jeon YJ, Jung N, Park JW, Park HY, Jung, SC (2015). Epithelial-mesenchy-
mal transition in kidney tubular epithelial cells induced by globotriaosyl-
sphingosine and globotriaosylceramide. PLoS One 10, e0136442.
Jurmeister S, Baumann M, Balwierz A, Keklikoglou I, Ward A, Uhlmann S, 
Zhang JD, Wiemann S, Sahin O (2012). MicroRNA-200c represses mi-
gration and invasion of breast cancer cells by targeting actin-regulatory 
proteins FHOD1 and PPM1F. Mol Cell Biol 32, 633–651.
Kalluri R, Neilson EG (2003). Epithelial-mesenchymal transition and its impli-
cations for fibrosis. J Clin Invest 112, 1776–1784.
Kalluri R, Weinberg RA (2009). The basics of epithelial-mesenchymal transi-
tion. J Clin Invest 119,1420–1428.
Karthikeyan S, Leung T, Ladias JA (2002). Structural determinants of 
the Na+/H+ exchanger regulatory factor interaction with the beta 2 
adrenergic and platelet-derived growth factor receptors. J Biol Chem 
277,18973–18978.
Korol A, Taiyab A, West-Mays JA (2016). RhoA/ROCK signaling regulates 
TGFbeta-induced epithelial-mesenchymal transition of lens epithelial 
cells through MRTF-A. Mol Med 22, 713–723.
Krainer E., Ouderkirk JL, Miller EW, Miller MR, Mersich AT, Blystone SD 
(2013). The multiplicity of human formins: expression patterns in cells 
and tissues. Cytoskeleton 70, 424–38.
Lamouille S, Derynck R (2007). Cell size and invasion in TGF-beta-induced 
epithelial to mesenchymal transition is regulated by activation of the 
mTOR pathway. J Cell Biol 178, 437–451.
Volume 29 June 15, 2018 Formins regulate TGF-β signaling for EMT | 1475 
Lamouille S, Xu J, Derynck R (2014). Molecular mechanisms of epithelial-
mesenchymal transition. Nat Rev Mol Cell Biol 15, 178–196.
Li JG, Chen C, Liu-Chen LY (2002). Ezrin-radixin-moesin-binding phospho-
protein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks 
U50,488H-induced down-regulation of the human kappa opioid recep-
tor by enhancing its recycling rate. J Biol Chem 277, 27545–27552.
Li Y, Zhu X, Zeng Y, Wang J, Zhang X, Ding YQ, Liang L (2010). FMNL2 
enhances invasion of colorectal carcinoma by inducing epithelial-mesen-
chymal transition. Mol Cancer Res 8, 1579–1590.
Mattila PK, Batista FD, Treanor B (2016). Dynamics of the actin cytoskeleton 
mediates receptor cross talk: an emerging concept in tuning receptor 
signaling. J Cell Biol 212, 267–280.
Maudsley S, Zamah AM, Rahman N, Blitzer JT, Luttrell LM, Lefkowitz RJ, 
Hall RA (2000). Platelet-derived growth factor receptor association with 
Na(+)/H(+) exchanger regulatory factor potentiates receptor activity. Mol 
Cell Biol 20, 8352–8363.
May RC, Hall ME, Higgs HN, Pollard TD, Chakraborty T, Wehland J, 
Machesky LM, Sechi AS (1999). The Arp2/3 complex is essential for the 
actin-based motility of Listeria monocytogenes. Curr Biol 9, 759–762.
Miettinen PJ, Ebner R, Lopez AR, Derynck R (1994). TGF-beta induced 
transdifferentiation of mammary epithelial cells to mesenchymal cells: 
involvement of type I receptors. J Cell Biol 127, 2021–2036.
Miranda MZ, Bialik JF, Speight P, Dan Q, Yeung T, Szászi K, Pedersen 
SF, Kapus A (2017) TGF-β1 regulates the expression and transcrip-
tional activity of TAZ protein via a Smad3-independent, myocardin-
related transcription factor-mediated mechanism. J Biol Chem 292, 
14902–14920.
Mori M, Nakagami H, Koibuchi N, Miura K, Takami Y, Koriyama H, Hayashi 
H, Sabe H, Mochizuki N, Morishita R, Kaneda Y (2009). Zyxin medi-
ates actin fiber reorganization in epithelial-mesenchymal transition 
and contributes to endocardial morphogenesis. Mol Biol Cell 20, 
3115–3124.
Muehlich S, Rehm M, Ebenau A, Goppelt-Struebe M (2017) Synergistic in-
duction of CTGF by cytochalasin D and TGFβ-1 in primary human renal 
epithelial cells: role of transcriptional regulators MKL1, YAP/TAZ and 
Smad2/3. Cell Signal 29, 31–4.
Muthusamy BP, Budi EH, Katsuno Y, Lee MK, Smith SM, Mirza AM, Akhurst 
RJ, Derynck R. (2015). ShcA protects against epithelial-mesenchymal 
transition through compartmentalized inhibition of TGF-beta-induced 
Smad activation. PLoS Biol 13, e1002325.
Nolen BJ, Tomasevic N, Russell A, Pierce DW, Jia Z, McCormick CD, 
Hartman J, Sakowicz R, Pollard TD (2009). Characterization of two 
classes of small molecule inhibitors of Arp2/3 complex. Nature 460, 
1031–1034.
O’Connor JW, Gomez EW (2013). Cell adhesion and shape regulate TGF-
beta1-induced epithelial-myofibroblast transition via MRTF-A signaling. 
PLoS One 8, e83188.
O’Connor JW, Mistry K, Detweiler D, Wang C, Gomez EW (2016). Cell-cell 
contact and matrix adhesion promote alphaSMA expression during 
TGFbeta1-induced epithelial-myofibroblast transition via Notch and 
MRTF-A. Sci Rep 6, 26226.
Penheiter SG, Mitchell H, Garamszegi N, Edens M, Dore JJ Jr, Leof EB 
(2002). Internalization-dependent and -independent requirements for 
transforming growth factor beta receptor signaling via the Smad path-
way. Mol Cell Biol 22, 4750–4759.
Podkowa M, Christova T, Zhao X, Jian Y, Attisano L (2013). p21-Activated 
kinase (PAK) is required for bone morphogenetic protein (BMP)-induced 
dendritogenesis in cortical neurons. Mol Cell Neurosci 57, 83–92.
Rana MK, Srivastava J, Yang M, Chen CS, Barber DL (2015). Hypoxia in-
creases the abundance but not the assembly of extracellular fibronectin 
during epithelial cell transdifferentiation. J Cell Sci 128, 1083–1089.
Razani B, Zhang XL, Bitzer M, von Gersdorff G, Bottinger EP, Lisanti MP 
(2001). Caveolin-1 regulates transforming growth factor (TGF)-beta/
SMAD signaling through an interaction with the TGF-beta type I recep-
tor. J Biol Chem 276, 6727–6738.
Rizvi SA, Neidt EM, Cui J, Feiger Z, Skau CT, Gardel ML, Kozmin SA, Kovar 
DR (2009). Identification and characterization of a small molecule inhibi-
tor of formin-mediated actin assembly. Chem Biol 16, 1158–1168.
Rys JP, DuFort CC, Monteiro DA, Baird MA, Oses-Prieto JA, Chand S, 
Burlingame AL, Davidson MW, Alliston TN (2015). Discrete spatial 
organization of TGFβ receptors couples receptor multimerization and 
signaling to cellular tension. Elife 4, e09300.
Salvi A, Thanabalu T (2017) WIP promotes in-vitro invasion ability, anchor-
age independent growth and EMT progression of A549 lung adenocar-
cinoma cells by regulating RhoA levels. Biochem Biophys Res Commun 
482, 1353–1359.
Sandbo N, Ngam C, Torr E, Kregel S, Kach J, Dulin N (2013) Control of 
myofibroblast differentiation by microtubule dynamics through a regu-
lated localization of mDia2. J Biol Chem 288, 15466–15473.
Schonichen A, Geyer M (2010). Fifteen formins for an actin filament: a 
molecular view on the regulation of human formins. Biochim Biophys 
Acta 1803, 152–163.
Shi W, Sun C, He B, Xiong W, Shi X, Yao D, Cao X. (2004). GADD34-PP1c 
recruited by Smad7 dephosphorylates TGFbeta type I receptor. J Cell 
Biol 164, 291–300.
Tavares AL, Mercado-Pimentel ME, Runyan RB, Kitten GT (2006). TGF beta-
mediated RhoA expression is necessary for epithelial-mesenchymal tran-
sition in the embryonic chick heart. Develop Dynam 235, 1589–1598.
Tu K, Li J, Verma VK, Liu C, Billadeau DD, Lamprecht G, Xiang X, Guo L, 
Dhanasekaran R, Roberts LR, et al (2015). Vasodilator-stimulated phos-
phoprotein promotes activation of hepatic stellate cells by regulating 
Rab11-dependent plasma membrane targeting of transforming growth 
factor beta receptors. Hepatology 61, 361–374.
Welch MD, Iwamatsu A, Mitchison TJ (1997). Actin polymerization is 
induced by Arp2/3 protein complex at the surface of Listeria monocyto-
genes. Nature 385, 265–269.
Westendorf JJ, Koka S (2004). Identification of FHOD1-binding proteins and 
mechanisms of FHOD1-regulated actin dynamics. J Cell Biochem 92, 
29–41.
Xi Y, Tan K, Brumwell AN, Chen SC, Kim YH, Kim TJ, Wei Y, Chapman HA 
(2014). Inhibition of epithelial-to-mesenchymal transition and pulmonary 
fibrosis by methacycline. Am J Respir Cell Mol Biol 50, 51–60.
Xie Y, Tan EJ, Wee S, Manser E, Lim L, Koh CG (2008). Functional interac-
tions between phosphatase POPX2 and mDia modulate RhoA path-
ways. J Cell Sci 121, 514–521.
Xu J, Lamouille S, Derynck R (2009). TGF-beta-induced epithelial to mesen-
chymal transition. Cell Res 19, 156–172.
Yang Q, Zhang XF, Pollard TD, Forscher P (2012). Arp2/3 complex-depen-
dent actin networks constrain myosin II function in driving retrograde 
actin flow. J Cell Biol 197, 939–956.
